We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New $30 million manufacturing facility in Burlington, Ontario, will allow company to manage R&D in-house and scale production without reliance on third-party manufacturers
Novartis and Sandoz already have some experience with the medical marijuana industry, having struck a deal last year to distribute products for a Canadian company that sells medical cannabis products in its home country and in Europe.